rational
emphysema
osteoporosi
epidemiolog
associ
diseas
cigarett
smoker
causal
mechan
link
ill
unknown
hypothes
autoimmun
respons
may
involv
disord
object
discov
antigenspecif
autoimmun
respons
associ
emphysema
osteoporosi
among
smoker
method
replic
nonbias
discoveri
assay
indic
autoimmun
glucos
regul
protein
endoplasm
reticulum
chaperon
cell
surfac
signal
receptor
present
mani
smoker
subject
assess
includ
spirometri
chest
ct
scan
dual
xray
absorptiometri
immunoblot
igg
autoantibodi
isol
patient
plasma
affin
chromatographi
leukocyt
function
assess
flow
cytometri
solubl
metabolit
mediat
measur
immunoassay
measur
main
result
circul
igg
autoantibodi
detect
plasma
specimen
smoke
subject
autoantibodi
singularli
preval
among
subject
radiograph
emphysema
ci
p
autoantibodi
also
associ
osteoporosi
ci
p
increas
circul
bone
metabolit
p
among
emphysemat
subject
protein
autoantigen
tcell
stimul
lymphocyt
prolifer
p
ifngamma
product
p
patientderiv
autoantibodi
avid
osteoclast
macrophag
increas
macrophag
nfkb
phosphoryl
p
product
p
respect
conclus
humor
cellular
autoimmun
respons
smoker
numer
biologicallyrelev
proinflammatori
deleteri
action
associ
emphysema
osteoporosi
find
may
relev
pathogenesi
smokingassoci
diseas
develop
biomark
immunoassay
andor
novel
treatment
disord
emphysema
defin
radiolog
andor
histolog
evid
lung
parenchym
destruct
account
enorm
worldwid
morbid
mortal
emphysema
among
tobacco
smoker
often
occur
associ
chronic
obstruct
pulmonari
diseas
copd
complex
syndrom
typifi
airway
narrow
inflamm
diagnos
presenc
expiratori
airflow
obstruct
spirometr
test
nonetheless
emphysema
copd
mean
invari
concord
mani
patient
sever
afflict
one
lung
abnorm
may
littl
evid
addit
directli
attribut
disabl
prematur
death
smokingassoci
lung
diseas
also
link
mani
system
abnorm
includ
vasculopathi
lung
cancer
renal
dysfunct
osteoporosi
abnorm
often
patholog
bone
deminer
occur
smoker
particularli
notabl
highli
relat
presenc
sever
emphysema
independ
coexist
magnitud
copd
per
se
tobacco
smoke
singl
greatest
risk
factor
develop
lung
diseas
industri
societi
addit
mechan
also
import
sinc
fraction
heavi
smoker
sever
clinic
manifest
moreov
symptomat
patholog
radiograph
featur
highli
variabl
among
afflict
individu
famili
cluster
case
evid
disord
often
progress
despit
smoke
cessat
pathophysiolog
process
caus
promot
emphysema
comorbid
remain
enigmat
although
system
immunolog
respons
includ
action
activ
monocytelineag
phagocyt
implic
disord
adapt
immun
respons
varieti
autoantigen
appear
common
among
patient
lung
diseas
attribut
smoke
unspecifi
autoantibodi
smoker
shown
induc
pulmonari
epitheli
cell
cytotox
vitro
immun
complex
complement
deposit
import
mediat
autoantibodyinduc
tissu
injuri
abnorm
also
preval
diseas
lung
smoker
nonetheless
report
autoimmun
patient
smokingrel
lung
diseas
date
correl
rather
mechanist
knowledg
moreov
antigenspecif
immun
respons
yet
implic
system
comorbid
pulmonari
disord
given
system
natur
mani
immunolog
process
hypothes
autoimmun
respons
could
contribut
lung
parenchyma
destruct
may
also
involv
pathogenesi
one
extrapulmonari
comorbid
associ
emphysema
accordingli
conduct
investig
identifi
antigenspecif
autoimmun
respons
relev
emphysema
osteoporosi
smokeexpos
subject
clinic
immunolog
correl
studi
perform
consecut
subject
packyear
cigarett
smoke
age
year
old
recruit
auspic
special
center
clinic
orient
research
sccor
registri
univers
pittsburgh
medic
center
subject
unstabl
cardiovascular
diseas
malign
chronic
oral
steroid
use
bmi
exclud
subject
complet
demograph
medic
histori
questionnair
chest
ct
scan
spirometri
lung
volum
diffus
capac
dlco
measur
use
standard
method
refer
equat
healthi
neversmok
control
subject
recruit
solicit
hospit
personnel
protocol
approv
univers
pittsburgh
investig
review
board
subject
provid
written
inform
consent
chest
ct
examin
perform
gener
electr
ge
lightspe
vct
scanner
radiat
exposur
ma
singl
expert
radiologist
blind
subject
ident
characterist
interpret
ct
imag
use
valid
semiquantit
visual
score
system
defin
emphysema
sever
none
trace
minim
mild
moder
sever
sever
correspond
visual
emphysema
group
previous
shown
visual
emphysema
score
associ
clinic
import
outcom
smoker
valid
compar
assess
radiograph
measur
emphysema
also
establish
plasma
obtain
centrifug
heparin
phlebotomi
specimen
peripher
blood
mononuclear
cell
pbmnc
isol
densitygradi
centrifug
serum
obtain
supernat
clot
nonheparin
blood
dxa
measur
bone
miner
densiti
bmd
hip
lumbar
spine
ad
subject
assess
initi
enrol
sccor
avail
last
smoke
subject
provid
plasma
immunolog
studi
bone
miner
densiti
bmd
measur
hip
lumbar
spine
use
holog
discoveri
bone
densitomet
previous
detail
method
bmd
report
score
number
standard
deviat
young
gender
ethnicspecif
refer
mean
score
defin
osteoporosi
cell
isol
pbmnc
normal
nonsmok
human
use
immunomagnet
bead
miltenyi
biotec
auburn
ca
differenti
presenc
mcsf
brief
cell
cultur
day
complet
rpmi
fc
also
supplement
ngml
mcsf
r
system
minneapoli
mn
chang
everi
day
flow
cytometri
confirm
cell
harvest
day
seven
express
intracellular
osteoclast
deriv
two
healthi
bone
marrow
donor
volunt
mononuclear
cell
within
bone
marrow
aspir
isol
densiti
gradient
centrifug
incub
amem
fc
overnight
nonadher
cell
collect
cultur
day
media
supplement
ngml
mcsf
ngml
rankl
r
system
frequent
replenish
nonbias
discoveri
assay
result
identif
autoreact
glucos
regul
protein
among
smoker
lung
diseas
parallel
report
previous
brief
hypothes
priori
autoantigen
associ
smokingrel
emphysema
could
identifi
use
patientderiv
igg
antibodi
immunoprecipit
autoantigen
cell
lysat
biolog
valid
put
autoimmun
could
substanti
demonstr
correl
presenc
humor
autoreact
selfprotein
diseas
preval
addit
evid
could
provid
find
concurr
tcell
autoreact
hla
bia
discov
diseaserelev
function
effect
autoantibodi
i
pool
circul
igg
antibodi
isol
six
emphysemat
subject
known
autoantibodi
previou
studi
use
immunoprecipit
autoantigen
cell
lysat
igg
subject
anoth
prepar
six
normal
control
specimen
isol
protein
g
adher
coval
crosslink
protein
column
hp
spintrap
ge
healthcar
piscataway
new
jersey
per
manufactur
protocol
cell
lysat
preadsorb
normal
iggprotein
column
appli
emphysema
iggprotein
column
extens
wash
put
iggbound
autoantigen
elut
acidif
ph
neutral
concentr
centrifug
sizefiltr
millipor
bellerica
identifi
two
dimens
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
gel
imag
typhoon
trio
ge
healthcar
analyz
imag
quanttl
softwar
ge
healthcar
individu
protein
harvest
spot
pick
ettan
spot
picker
ge
healthcar
trypsin
digest
sequenc
matrixassist
laser
adsorptionion
tandem
time
flight
mass
spectrometri
malditoftof
appli
biosystem
carlsbad
ca
unpublish
find
previou
investig
indic
presenc
autoantibodi
specif
cryptic
kda
cell
antigen
tend
associ
diseas
manifest
among
smoker
henc
discoveri
potenti
autoantigen
size
particular
interest
glucos
regul
protein
member
heat
shock
protein
famili
identifi
two
sequenti
discoveri
assay
addit
appropri
size
seem
worthi
focu
addit
studi
potenti
autoantigen
smoker
given
myriad
cellular
function
role
known
autoantigen
immunolog
disord
immunoblot
highli
specif
gold
standard
method
detect
antibodi
assay
perform
use
modif
previous
describ
method
brief
recombin
purchas
prospec
rehovot
israel
prepar
bulk
solut
aliquot
frozen
use
volum
correspond
two
hundr
fifti
ng
concurr
ad
multipl
lane
run
gel
nupag
bistri
invitrogen
carlsbad
ca
electrophores
protein
transfer
nitrocellulos
membran
block
dri
milk
ttb
mm
tri
hcl
ph
mm
nacl
tween
membran
strip
separ
section
individu
incub
overnight
particular
subject
plasma
specimen
dilut
laboratori
investig
perform
assay
rak
jx
ab
concurr
incub
multipl
subject
plasma
specimen
one
individu
membran
strip
avail
gel
plu
posit
neg
control
well
molecular
weight
marker
complet
oblivi
subject
ident
diseas
manifest
pilot
studi
shown
dilut
optim
distinguish
emphysemat
normal
popul
wherea
dilut
specimen
seldom
posit
diseas
subject
specimen
never
posit
among
normal
specimen
strip
wash
ttb
incub
one
hour
dilut
chicken
antihuman
igg
conjug
horseradish
peroxidas
hrp
thermo
scientif
rockfort
il
anoth
wash
hrp
detect
addit
super
signal
west
pico
chemiluminesc
substrat
thermo
scientif
instantan
exposur
radiograph
film
score
posit
neg
unanim
consensu
three
investig
blind
subject
ident
clinic
characterist
figur
file
equivoc
specimen
repeat
blind
judg
agreement
tissu
cm
dissect
emphysemat
lung
explant
therapeut
transplant
cadaver
normal
lung
use
donor
organ
specimen
fix
neutral
buffer
znformalin
paraffin
embed
section
immunohistochemistri
ihc
assay
bronchoalveolar
lavag
fluid
balf
obtain
lung
explant
wedg
steril
mm
plastic
tube
segment
bronchi
success
infus
aspir
ml
pb
aliquot
use
syring
balf
centrifug
g
supernat
filter
mm
concentr
use
kda
centrifugations
filter
millipor
billerica
quantifi
bicinchonin
acid
bca
assay
thermo
scientif
alveolar
macrophag
within
balf
isol
plastic
adher
immunohistochemistri
use
assess
situ
express
paraffinembed
lung
tissu
section
brief
immunostain
perform
rabbit
monoclon
antibodi
direct
cell
signal
technolog
danver
employ
citrat
antigen
retriev
per
manufactur
recommend
biotinyl
goat
antirabbit
igg
jackson
immunoresearch
west
grove
pa
ab
complex
hrp
vector
laboratori
burlingam
ca
imag
method
previous
detail
balf
detect
immunoblot
concentr
balf
mcg
protein
specimen
electrophores
process
describ
membran
incub
dilut
mous
antihuman
mab
r
system
follow
dilut
chicken
antimous
igghrp
santa
cruz
biotechnolog
santa
cruz
ca
immunoblot
method
valid
use
commerci
lysat
normal
human
deriv
macrophag
figur
file
igg
pool
plasma
specimen
six
emphysema
patient
known
autoantibodi
prior
immunoblot
assay
isol
adher
protein
g
igg
appli
rgrp
crosslink
aminolink
plu
gel
spin
column
thermo
scientif
follow
manufactur
protocol
extens
wash
elut
acidif
ph
neutral
concentr
use
kda
centrifug
filter
valid
igg
characterist
specif
avid
figur
file
eleven
ml
plasma
yield
mcg
igg
endotoxin
concentr
within
autoantibodi
prepar
detect
threshold
limulu
amebocyt
lysat
assay
lal
chromogen
endotoxin
quantit
kit
thermo
scientif
ie
mcg
autoantibodi
platebound
normal
alveolar
macrophag
balf
n
bone
marrow
osteoclast
n
preincub
bovin
serum
albumin
azidefre
fc
receptor
blocker
innovex
bioscienc
richmond
ca
wash
cell
incub
minut
mcgml
patientderiv
igg
concentr
pool
normal
human
igg
anoth
wash
cell
incub
fitcconjug
antihuman
igg
antibodi
immunoconcept
sacramento
ca
assess
fluoresc
microscopi
detail
previous
media
remov
concurr
autolog
macrophag
cultur
cell
incub
mcgml
either
normal
human
igg
minut
media
replac
cell
supernat
harvest
hour
macrophag
suspend
fix
permiabil
stain
antinfkb
alexfluor
cell
signal
technolog
danver
specif
phosphoryl
nfkb
subunit
mean
fluoresc
intens
normal
iggtreat
macrophag
compar
live
cell
analyz
use
bd
facscalibur
bd
bioscienc
san
jose
ca
flow
cytometri
gate
establish
use
control
fluorochrom
posit
neg
macrophag
includ
isotyp
control
detail
elsewher
macrophag
supernat
analyz
mediat
product
use
proteinsuspend
bead
array
platform
multiplex
kit
biorad
hercul
ca
follow
manufactur
protocol
collagen
type
ctelopeptid
ctx
measur
sera
sandwich
immunoassay
use
ctx
reagent
elecsi
roch
indianapoli
accord
manufactur
protocol
type
ntermin
procollagen
plasma
specimen
measur
use
radioimmunoassay
kit
orion
diagnostica
espoo
finland
allel
preval
determin
leukocyt
dna
pcrssp
assess
particular
allel
prompt
recent
find
overrepres
among
idiopath
pulmonari
fibrosi
ipf
patient
clinicallyrelev
autoimmun
pbmnc
collect
consecut
sccor
subject
cultur
five
day
complet
media
presenc
ad
protein
baselin
control
test
antigen
ie
elastin
split
product
esp
esp
purchas
elastin
product
compani
owensvil
mo
test
antigen
boil
minut
cool
ice
immedi
prior
use
obviat
nonspecif
mitogen
effect
ad
cultur
final
concentr
mgml
pilot
studi
shown
consist
relationship
test
antigen
concentr
rang
mcgml
assay
result
prolifer
determin
incorpor
bromodeoxyuridin
brdu
ad
two
day
prior
cell
harvest
measur
gate
tcell
establish
flow
cytometri
detail
previous
specif
indic
si
prolifer
calcul
tcell
incorpor
brdu
cultur
supplement
respect
test
antigen
minu
incorpor
concurr
unstimul
control
cultur
intracellular
ifngamma
product
last
cohort
cultur
specimen
also
assess
flow
cytometri
use
method
fulli
detail
previous
specif
indic
si
ifngamma
product
calcul
tcell
produc
cytokin
cultur
ad
test
antigen
minu
cytokin
product
concurr
unstimul
control
cultur
order
continu
data
compar
mannwhitney
test
wilcoxon
sign
rank
test
compar
result
two
assay
specimen
bonferroni
correct
multipl
comparison
dichotom
outcom
analyz
chisquar
odd
ratio
confid
interv
ci
calcul
univari
logist
regress
multivari
logist
regress
analysi
use
adjust
confound
factor
alpha
level
consid
signific
data
analyz
use
sa
characterist
smokeexposur
cohort
detail
tabl
major
n
smoke
subject
one
lung
abnorm
ie
copd
andor
emphysema
onehundr
thirtythre
subject
expiratori
airflow
obstruct
spirometri
ie
copd
also
emphysema
convers
fortytwo
emphysemat
subject
normal
spirometri
anoth
distinct
cohort
healthi
control
never
smoke
n
year
old
male
preval
autoantibodi
greater
smoker
healthi
neversmok
control
p
latter
preval
similar
fals
posit
rate
diseaseassoci
autoantibodi
healthi
popul
femal
overrepres
among
smoker
autoantibodi
tabl
autoantibodi
also
decreas
diffus
capac
although
pulmonari
function
test
well
medic
use
compar
autoantibodi
neg
subject
hla
class
ii
underrepres
among
smoker
autoantibodi
compar
subject
autoantibodi
neg
ci
p
preval
local
normal
popul
previous
found
signific
differ
autoantibodi
preval
smoker
copd
compar
normal
spirometri
p
signific
correl
autoreact
sever
airflow
obstruct
figur
howev
presenc
autoantibodi
significantli
associ
preval
figur
sever
emphysema
figur
multivari
analys
show
adjust
gender
sever
expiratori
airflow
obstruct
alter
relationship
posit
emphysema
ci
p
presenc
autoantibodi
also
highli
associ
decreas
bone
miner
densiti
osteoporosi
figur
remain
signific
multivari
adjust
gender
airflow
obstruct
sever
tobacco
burden
steroid
use
ci
p
circul
metabolit
bone
turnov
also
greatest
subject
autoantibodi
figur
given
associ
autoreact
emphysema
abnorm
bone
miner
post
hoc
analysi
perform
compar
autoantibodi
preval
subject
concurr
emphysema
low
bmd
vs
remain
smoke
cohort
autoantibodi
preval
significantli
greater
subject
emphysema
osteopenia
vs
ci
even
among
emphysema
osteoporosi
vs
ci
gender
stratifi
analysi
show
relationship
strongest
male
figur
protein
increas
emphysema
specimen
predominantli
local
alveolar
epitheli
cell
macrophag
figur
concentr
also
much
greater
balf
diseas
lung
compar
normal
control
prepar
figur
order
explor
possibl
autoantibodi
action
relev
emphysema
osteoporosi
first
examin
macrophag
osteoclast
bind
igg
isol
patient
plasma
ifa
show
autoantibodi
avid
cell
figur
test
direct
functionalt
effect
patientderiv
autoantibodi
incub
overnight
macrophag
treatment
result
increas
macrophag
nfkb
activ
figur
augment
product
figur
figur
figur
figur
autoantibodi
airflow
obstruct
emphysema
autoantibodi
preval
significantli
associ
copd
sever
gold
stage
number
within
column
denot
subject
n
b
autoantibodi
significantli
associ
emphysema
preval
smoke
subject
odd
ratio
ci
confid
interv
c
emphysema
score
per
ct
also
significantli
greater
among
subject
autoantibodi
diseaseassoci
autoantibodi
respons
also
accompani
concurr
tcell
respons
autoantigen
addit
heatdenatur
protein
pbmnc
cultur
smoker
induc
prolifer
tcell
unlik
effect
denatur
esp
figur
moreov
magnitud
prolif
respons
greatest
among
tcell
emphysemat
smoker
figur
tcell
ifngamma
product
also
uniqu
increas
cultur
figur
especi
prepar
subject
emphysema
figur
induc
prolifer
ifngamma
product
tcell
normal
nonsmok
subject
data
shown
ipf
patient
autoimmun
frequent
complic
numer
vari
primari
injuri
respons
microbiom
within
smokedamag
lung
postul
highli
immunogen
henc
like
predisposit
develop
autoimmun
neoantigen
gener
reactiv
constitu
within
tobacco
smoke
also
provok
autoimmun
respons
secondari
autoimmun
respons
benign
clinic
irrelev
case
highli
pathogen
injuri
howev
exampl
carditi
associ
microbi
figur
autoantibodi
associ
osteoporosi
bone
metabol
marker
concurr
low
bone
densiti
emphysema
score
left
panel
osteoporosi
preval
eitherboth
hip
spine
right
panel
among
smoke
cohort
b
serum
level
bone
turnov
metabolit
collagen
type
crosslink
ctelopeptid
ctx
greatest
among
smoker
autoantibodi
lowest
second
lowest
middl
second
highest
highest
line
repres
th
th
median
th
th
percentil
respect
mean
denot
solid
squar
c
serum
level
bone
turnov
metabolit
type
ntermin
procollagen
greatest
among
smoker
autoantibodi
relationship
autoantibodi
posit
concurr
coexist
low
bmd
emphysema
smoker
signific
gender
greatest
male
infect
neurolog
syndrom
link
malign
myriad
tissuespecif
autoimmun
disord
adapt
immun
respons
smoker
sever
featur
classic
autoimmun
biolog
plausibl
particular
autoimmun
respons
condit
presenc
correspond
autoantigen
target
organ
highli
express
lung
especi
diseas
specimen
figur
hla
haplotyp
major
often
strongest
known
genet
determin
autoimmun
suscept
find
distinct
hla
allel
overor
underrepres
confer
predilect
protect
respect
within
defin
diseas
popul
hallmark
autoimmun
disord
appear
protect
smoker
product
diseaseassoci
autoantibodi
result
obvers
analog
studi
ipf
patient
overrepres
among
autoantibodi
heat
shock
protein
stress
respons
protein
consider
sequenc
homolog
dispar
find
thu
indic
biologicallydistinct
antigenand
diseasespecif
autoimmun
respons
rather
gener
epiphenomenon
lung
diseas
compellingli
increas
preval
autoantibodi
emphysemat
smoker
defin
criteria
abnorm
autoreact
pathogen
igg
smoker
least
impli
stringent
independ
overlap
associ
specif
autoantibodi
concurr
emphysema
osteoporosi
increas
bone
turnov
furthermor
find
show
patientderiv
autoantibodi
activ
monocytelineag
phagocyt
enhanc
product
injuri
mediat
implic
genesi
emphysema
osteoporosi
direct
evid
deleteri
autoantibodi
effect
particular
igg
treatment
increas
cellular
elabor
aka
potent
proinflammatori
chemoattract
neutrophil
monocytesmacrophag
respect
mediat
also
stimul
osteoclastogenesi
increas
among
patient
osteoporosi
emphysema
incub
also
increas
macrophag
product
type
iv
collagenas
produc
macrophag
osteoclast
promot
enzymat
breakdown
extracellular
matrix
imput
causal
contribut
role
lung
parenchyma
destruct
pulmonari
metastas
bone
resorpt
moreov
vari
effect
occur
limit
hour
macrophag
exposur
subphysiolog
concentr
mgml
autoantibodi
seem
possibl
even
greater
effect
might
result
incub
autoantibodi
concentr
found
vivo
mgml
longer
period
cumul
effect
increas
inflamm
proteas
activ
target
tissu
mani
monthstoyear
may
especi
deleteri
emphysema
osteoporosi
typic
promin
among
middleag
elderli
smoker
situ
pathogen
autoimmun
smoker
also
strongli
support
find
stress
respons
protein
autoantigen
tcell
subject
especi
among
emphysema
tcell
inert
anatom
access
selfconstitu
healthi
subject
wherea
overt
reactiv
lymphocyt
protein
abund
diseas
organ
figur
gold
standard
autoimmun
diseas
antigen
autoantigen
stimul
tcell
protean
typic
injuri
action
includ
elabor
numer
mediat
recruit
activ
divers
leukocyt
somat
effector
cell
find
tcell
autoreact
unlik
benign
epiphenomenon
increas
product
ifngamma
particular
figur
believ
import
factor
pathogenesi
smokingassoci
lung
diseas
furthermor
reactiv
tcell
emphysemat
subject
simpli
attribut
global
nonspecif
hyperact
sinc
elastin
split
product
esp
inert
figur
although
esp
previous
report
autoantigen
emphysema
unabl
replic
find
similarli
neg
studi
report
investig
also
frequent
antigen
autoimmun
syndrom
express
extracellular
export
upregul
vari
stress
includ
viral
infect
smoke
inhal
ongo
immunolog
respons
initi
direct
antigen
peptid
may
gener
coassoci
chaperon
protein
bystand
mechan
andor
epitop
spread
subsequ
injuri
infect
could
caus
upregul
newli
antigen
potenti
creat
posit
feedback
loop
promot
immun
respons
diseas
progress
specif
mechan
autoantibodi
affect
phagocyt
yet
unknown
focu
ongo
investig
laboratori
addit
intracellular
action
endoplasm
reticulum
protein
transport
scaveng
import
unfold
protein
respons
cell
surfac
extracellular
mediat
antiinflammatori
proresolutori
effect
might
counter
action
decreas
concentr
bioavail
immunomodulatori
extracellular
andor
activ
signal
transduct
pathway
crosslink
cell
surfac
autoreact
notabl
preval
among
subject
rheumatoid
arthriti
anoth
smokingassoci
diseas
autoantibodi
patient
also
enhanc
macrophag
proinflammatori
function
mechan
still
unknown
find
autoreact
lend
support
evolv
paradigm
autoimmun
pathogenesi
smokingassoci
lung
diseas
present
studi
show
respons
smoker
manifest
activ
autoantigenspecif
tcell
process
lead
numer
deleteri
consequ
igg
autoantibodi
directli
exert
proinflammatori
effect
even
pathogen
action
complet
discount
multipl
strong
clinicalimmunolog
associ
indic
assay
specif
autoimmun
respons
may
use
identifi
smoker
atrisk
interrel
disord
nonetheless
find
need
addit
corrobor
refin
adopt
autoimmun
assay
clinic
manag
smoke
patient
addit
mani
immun
diseas
antibodymedi
lung
disord
particular
refractori
treatment
nonspecif
immunosuppress
regimen
eg
glucocorticoid
convers
howev
specif
therapi
directli
target
patholog
autoimmun
process
includ
autoantibodi
remov
interrupt
autoantibodi
product
per
se
often
clinic
efficaci
import
ultim
result
present
studi
relat
report
may
draw
attent
potenti
novel
treatment
mechanisticallyfocus
critic
stage
autoimmun
cascad
prevent
figur
tcell
autoreact
addit
pbmnc
cultur
increas
tcell
prolifer
brdu
uptak
rel
media
control
ad
protein
n
unlik
addit
elastin
split
product
esp
p
c
denot
alpha
level
correct
multipl
comparison
b
tcell
prolifer
greatest
among
cultur
smoker
emphysema
n
specif
indic
si
prolifer
calcul
tcell
incorpor
brdu
cultur
minu
incorpor
concurr
media
control
c
also
increas
percentag
tcell
produc
ifngamma
unlik
effect
esp
ifngamma
product
also
greatest
tcell
emphysemat
smoker
specif
indic
si
calcul
tcell
produc
ifngamma
product
cultur
minu
concurr
control
